Literature DB >> 33419583

Rare coexistence of three novel CDCA7-ALK, FSIP2-ALK, ALK-ERLEC1 fusions in a lung adenocarcinoma patient who responded to Crizotinib.

Guojiang Zhao1, Lin Chen2, Mingzhe Xiao2, Shengli Yang3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33419583     DOI： 10.1016/j.lungcan.2020.12.013

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  3 in total

1.  Dysregulated Immune and Metabolic Microenvironment Is Associated with the Post-Operative Relapse in Stage I Non-Small Cell Lung Cancer.

Authors:  Shirong Zhang; Xiao Xiao; Xiuli Zhu; Xueqin Chen; Xiaochen Zhang; Jingjing Xiang; Rujun Xu; Zhuo Shao; Jing Bai; Yanping Xun; Yanping Jiang; Zhengzheng Chen; Xuefeng Xia; Hong Jiang; Shenglin Ma
Journal:  Cancers (Basel)       Date:  2022-06-22       Impact factor: 6.575

2.  Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma.

Authors:  Wanming Hu; Li Yuan; Xinke Zhang; Yang Ni; Dongchun Hong; Zhicai Wang; Xiaomin Li; Yuan Ling; Chao Zhang; Wanglong Deng; Minqi Tian; Ran Ding; Chao Song; Jianmin Li; Xing Zhang
Journal:  Cancer Sci       Date:  2022-03-10       Impact factor: 6.518

3.  Characterizing kinase intergenic-breakpoint rearrangements in a large-scale lung cancer population and real-world clinical outcomes.

Authors:  Y Yao; Z Yu; Y Ma; Q Ou; X Wu; D Lu; X Li
Journal:  ESMO Open       Date:  2022-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.